none

UBER CO-FOUNDER INVESTS IN PHARMECUTICAL DISRUPTION

01-09-2016
by 
in 

 Oscar Salazar, co-founder of Uber, and Walter Jin, founder of Carlyle Healthcare Group, have invested in Series-A funding round and joined the board of RxAdvance, a full service Pharmacy Benefits Management company.

Oscar Salazar is a co-founder of Pager, an innovative on-demand healthcare service that utilizes a mobile patient engagement platform to connect patients with the right type of care. Prior to Pager, Oscar was a founding partner and Chief Technology Officer of Uber.

“Our goal is to leverage disruptive technology and world-class design to reinvent healthcare and deliver cost savings and efficiencies," said Oscar and Walter.

“We are proud to join the RxAdvance board, as its accountable drug benefit management practice and risk-sharing business models are timely in this antiquated industry and are perfectly aligned with the healthcare investments in which we are involved.”

“In the recent years, several successful Silicon Valley entrepreneurs and blue chip companies have entered the healthcare vertical to disrupt and transform, in vain.

This lack of success can be attributed to the absence of substantial business and revenue models, disruptive service offerings, and a proven track record in the complex healthcare eco-system,” says John Sculley, former Apple CEO and Vice Chairman of RxAdvance."

“What impressed me about Ravi and his team at RxAdvance is that they have all the essential components for success - a widely proven and successful revenue model, a solid platform and innovative thinking, a proven track record, and deep healthcare domain expertise capable of disrupting traditional paradigms throughout the care continuum. Through its innovative Collaborative PBM Cloud™, RxAdvance is challenging large incumbent PBMs by disrupting their decades-old business and revenue models, and their risk-sharing models are unheard of in the PBM market.”

There is great synergy between RxAdvance and Pager. Both brands use world class technology and clinical resources to disrupt traditional healthcare delivery practices. Through their partnership, high quality healthcare services will be made more efficient, cost-effective, and convenient.

“We are honored to have two of the leading minds in disruptive technology and business as our investment partners and board members. We at RxAdvance feel that their high-tech experience and guidance will help to transform the $770 billion PBM and associated avoidable drug-impacted medical spend that is long overdue for innovation,” says Ravi Ika, President & CEO of RxAdvance.

Related news & editorials

  1. 16.08.2019
    16.08.2019
    by      In
    South Australian defence industry SMEs have won more than $8 million in funding from the Defence Innovation Hub to provide the Australian Defence Force with a capability edge.
    Federal Minister for Defence Industry Melissa Price says that this round of investments includes initial concept... Read More
  2. 16.08.2019
    16.08.2019
    by      In
    A new plasma coating for bone implants has been developed to help improve outcomes for patients by increasing the likelihood of an implant fusing to surrounding bone, and by reducing the chances of complications such as infection or rejection.
    An international research team, led by the University... Read More
  3. 16.08.2019
    16.08.2019
    by      In
    Communications company Motorola Solutions has appointed Con Balaskas as its new Managing Director for Australia and New Zealand. He has held multiple senior positions in a distinguished 20-year career with Motorola, and has played a pivotal role in the growth and expansion of the company’s managed... Read More
  4. 15.08.2019
    15.08.2019
    by      In
    Birdon America Inc, the US subsidiary of Port Macquarie maritime engineering and services company the Birdon Group, has been awarded two new contracts worth up to $575m, confirming its position as one of Australia’s foremost exporters to the US Departments of Defense and Homeland Security.
    One... Read More